Literature DB >> 16434023

Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.

Yoshihito Ide1, Eiji Miyoshi, Tsutomu Nakagawa, Jianguo Gu, Masahiro Tanemura, Toshiro Nishida, Toshinori Ito, Harumi Yamamoto, Yasunori Kozutsumi, Naoyuki Taniguchi.   

Abstract

The goal of this study was to identify glycosyltransferases that are specifically expressed in pancreatic cancer. To investigate the gene expression of glycosyltransferases between pancreatic cancer and normal pancreatic tissues, we performed DNA-microarray (involving about 1000 oligosaccharide-related genes) using RNA mixtures of pancreatic cancer cells and normal pancreatic tissues. Eighty-six genes were up-regulated and thirty-two were down-regulated in pancreatic cancer, compared to normal pancreatic tissue. Among these changes, it is noteworthy that the expression of GnT-IVa was decreased and the expression of GnT-IVb was increased in pancreatic cancer, compared to normal pancreatic tissues. Although GnT-IVa and -IVb are involved in the same reaction as a glycosyltransferase, their chromosomal localization is different. When 5 cases of pancreatic cancer tissues were examined using the real-time RT-PCR method, the expression of GnT-IVb was dominant in tumor tissues and the expression of GnT-IVa was dominant in the surrounding normal tissues. The expression of GnT-IVa was increased in all 3 cell lines that had been treated with 5-aza-C and butyrate. These results suggest that the down-regulation of GnT-IVa in pancreatic cancer cells is due to an epigenetic abnormality in the gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434023     DOI: 10.1016/j.bbrc.2005.12.208

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Genomics and epigenomics of the human glycome.

Authors:  Vlatka Zoldoš; Mislav Novokmet; Ivona Bečeheli; Gordan Lauc
Journal:  Glycoconj J       Date:  2012-05-31       Impact factor: 2.916

Review 2.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

3.  N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.

Authors:  Jianhui Fan; Shujing Wang; Shengjin Yu; Jingna He; Weilong Zheng; Jianing Zhang
Journal:  Glycoconj J       Date:  2012-06-27       Impact factor: 2.916

4.  Inflammatory Stress Causes N-Glycan Processing Deficiency in Ocular Autoimmune Disease.

Authors:  Ashley M Woodward; Sylvain Lehoux; Flavio Mantelli; Antonio Di Zazzo; Inka Brockhausen; Stefano Bonini; Pablo Argüeso
Journal:  Am J Pathol       Date:  2018-11-15       Impact factor: 4.307

Review 5.  Modulation of E-cadherin function and dysfunction by N-glycosylation.

Authors:  Salomé S Pinho; Raquel Seruca; Fátima Gärtner; Yoshiki Yamaguchi; Jianguo Gu; Naoyuki Taniguchi; Celso A Reis
Journal:  Cell Mol Life Sci       Date:  2010-11-23       Impact factor: 9.261

6.  Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.

Authors:  Francesca Demichelis; Sunita R Setlur; Samprit Banerjee; Dimple Chakravarty; Jin Yun Helen Chen; Chen X Chen; Julie Huang; Himisha Beltran; Derek A Oldridge; Naoki Kitabayashi; Birgit Stenzel; Georg Schaefer; Wolfgang Horninger; Jasmin Bektic; Arul M Chinnaiyan; Sagit Goldenberg; Javed Siddiqui; Meredith M Regan; Michale Kearney; T David Soong; David S Rickman; Olivier Elemento; John T Wei; Douglas S Scherr; Martin A Sanda; Georg Bartsch; Charles Lee; Helmut Klocker; Mark A Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-10       Impact factor: 11.205

7.  Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.

Authors:  Shinji Takamatsu; Aristotelis Antonopoulos; Kazuaki Ohtsubo; David Ditto; Yasunori Chiba; Dzung T Le; Howard R Morris; Stuart M Haslam; Anne Dell; Jamey D Marth; Naoyuki Taniguchi
Journal:  Glycobiology       Date:  2009-12-16       Impact factor: 4.313

8.  Compartmentalization of the Edinburgh Human Metabolic Network.

Authors:  Tong Hao; Hong-Wu Ma; Xue-Ming Zhao; Igor Goryanin
Journal:  BMC Bioinformatics       Date:  2010-07-22       Impact factor: 3.169

9.  Multiplexed surrogate analysis of glycotransferase activity in whole biospecimens.

Authors:  Chad R Borges; Douglas S Rehder; Paolo Boffetta
Journal:  Anal Chem       Date:  2013-02-15       Impact factor: 6.986

10.  Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.

Authors:  Kazuhiro Nouso; Maho Amano; Yoichi M Ito; Koji Miyahara; Yuki Morimoto; Hironari Kato; Koichiro Tsutsumi; Takeshi Tomoda; Naoki Yamamoto; Shinichiro Nakamura; Sayo Kobayashi; Kenji Kuwaki; Hiroaki Hagihara; Hideki Onishi; Yasuhiro Miyake; Fusao Ikeda; Hidenori Shiraha; Akinobu Takaki; Taku Nakahara; Shin-Ichiro Nishimura; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2013-01-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.